
In Vivo DNA Analysis 183
The most significant technical advantage of in vivo DMS footprinting is that
DMS can be simply added to the cell culture medium, requiring no cell
manipulation (see Table 2 for advantages and drawbacks). Each guanine resi-
due of purified DNA displays about the same probability of being methylated
by DMS. Because DNA inside living cells forms chromatin and is often found
associated with a number of proteins, it is expected that its reactivity toward
DMS will differ from purified DNA. Figures 6 and 7 show in vivo DMS treat-
ment patterns compared to the treatment of purified genomic DNA. Proteins in
contact with DNA either decrease accessibility of specific guanines to DMS
(protection) or, as frequently observed at the edges of a footprint, increase
reactivity (hyperreactivity) (1). Hyperreactivity can also indicate a greater
DMS accessibility of special in vivo DNA structures (19). Hot piperidine
cleaves the glycosylic bond of methylated guanines and adenines, leaving a
ligatable 5'-phosphate (20).
Genomic footprinting using DMS reveals DNA–protein contacts located in
the major groove of the DNA double helix (Table 1). However, it should be
noted that in vivo DNA studies using DMS alone may not detect some DNA–
protein interactions (21). First, no DNA–protein interaction will be detected in
the absence of guanine residues. Second, some proteins do not affect DNA
accessibility to DMS. Third, certain weak DNA–protein contacts could actually
be disrupted because of the high reactivity of the DMS. Thus when using DMS,
it is often important to also apply alternative footprinting approaches (21,22).
1.3. Photofootprint Analysis (Figs. 2 and 3)
Ultraviolet light (UVC: 200–280 nm; UVB: 280–320 nm) can also be used
as a modifying agent for in vivo footprinting (4,8,23–25). When cells are sub-
jected to UV light (UVC or UVB), two major classes of lesions may be intro-
duced into the DNA at dipyrimidine sequences (CT, TT, TC, and CC): the
cyclobutane pyrimidine dimer (CPD) and the pyrimidine (6–4) pyrimidone
photoproduct (6–4PP) (26). CPDs are formed between the 5,6 bonds of any
two adjacent pyrimidines, whereas a stable bond between positions 6 and 4
of two adjacent pyrimidines characterizes 6–4PPs. 6–4PP are formed at a rate
15–30% of that of CPDs (27) and are largely converted to their Dewar valence
as well as DNA structure can prevent (protection) or enhance (hypersensitive) DNase
I cleavage. The DNase I cleavage leaves phosphorylated 5' ends. On the sequencing
ladder following LMPCR, DNA sequences that are protected from DNase I cleavage
appear as missing or less intense bands when compared with the sequencing ladder
from the same DNA sequence obtained after DNase I digestion of purified DNA. On
the other hand, hypersensitive sites that undergo enhanced DNase I cleavage appear as
darker bands in the sequencing ladder relative to the purified DNA control.